93 related articles for article (PubMed ID: 9244358)
21. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
[TBL] [Abstract][Full Text] [Related]
22. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitin/proteasome-mediated degradation of p19INK4d determines its periodic expression during the cell cycle.
Thullberg M; Bartek J; Lukas J
Oncogene; 2000 Jun; 19(24):2870-6. PubMed ID: 10851091
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d.
Brotherton DH; Dhanaraj V; Wick S; Brizuela L; Domaille PJ; Volyanik E; Xu X; Parisini E; Smith BO; Archer SJ; Serrano M; Brenner SL; Blundell TL; Laue ED
Nature; 1998 Sep; 395(6699):244-50. PubMed ID: 9751051
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines.
Gemma A; Takenoshita S; Hagiwara K; Okamoto A; Spillare EA; McMemamin MG; Hussain SP; Forrester K; Zariwala M; Xiong Y; Harris CC
Int J Cancer; 1996 Nov; 68(5):605-11. PubMed ID: 8938142
[TBL] [Abstract][Full Text] [Related]
27. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
[TBL] [Abstract][Full Text] [Related]
28. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
Gill RM; Slack R; Kiess M; Hamel PA
Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
[TBL] [Abstract][Full Text] [Related]
29. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection.
Kim JW; Namkoong SE; Ryu SW; Kim HS; Shin JW; Lee JM; Kim DH; Kim IK
Gynecol Oncol; 1998 Jul; 70(1):75-9. PubMed ID: 9698478
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.
LaRue KE; Bradbury EM; Freyer JP
Cancer Res; 1998 Mar; 58(6):1305-14. PubMed ID: 9515820
[TBL] [Abstract][Full Text] [Related]
31. [Loss of CDKN2 gene and amplification of cyclin D1 gene in human esophageal cancer].
Zheng J; Hou P; Zhou C
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):408-11. PubMed ID: 9387288
[TBL] [Abstract][Full Text] [Related]
32. Trichostatin A activates p18INK4c gene: differential activation and cooperation with p19INK4d gene.
Yokota T; Matsuzaki Y; Sakai T
FEBS Lett; 2004 Sep; 574(1-3):171-5. PubMed ID: 15358560
[TBL] [Abstract][Full Text] [Related]
33. [Molecullar structure and function of the p16/INK4a/CDKN2/MTS1 and the INK4 family, and their association with carcinogenesis].
Okamoto A; Tanaka T
Nihon Rinsho; 1996 Apr; 54(4):1037-42. PubMed ID: 8920670
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of cyclin dependent kinase inhibitors, p16INK4a and p15INK4b gene, in acute lymphoblastic leukemias].
Kaname M; Watanabe H; Fukuchi K; Akagi Y; Takagi Y; Tomoyasu S; Tsuruoka N; Gomi K
Rinsho Byori; 1996 Aug; 44(8):771-7. PubMed ID: 8816064
[TBL] [Abstract][Full Text] [Related]
35. Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.
Guan KL; Jenkins CW; Li Y; O'Keefe CL; Noh S; Wu X; Zariwala M; Matera AG; Xiong Y
Mol Biol Cell; 1996 Jan; 7(1):57-70. PubMed ID: 8741839
[TBL] [Abstract][Full Text] [Related]
36. Features of macrophage differentiation induced by p19INK4d, a specific inhibitor of cyclin D-dependent kinases.
Adachi M; Roussel MF; Havenith K; Sherr CJ
Blood; 1997 Jul; 90(1):126-37. PubMed ID: 9207446
[TBL] [Abstract][Full Text] [Related]
37. The INK4 family of CDK inhibitors.
Carnero A; Hannon GJ
Curr Top Microbiol Immunol; 1998; 227():43-55. PubMed ID: 9479825
[No Abstract] [Full Text] [Related]
38. Frequency and structure of p53 rearrangements in human osteosarcoma.
Miller CW; Aslo A; Tsay C; Slamon D; Ishizaki K; Toguchida J; Yamamuro T; Lampkin B; Koeffler HP
Cancer Res; 1990 Dec; 50(24):7950-4. PubMed ID: 2253237
[TBL] [Abstract][Full Text] [Related]
39. Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation.
O'Farrell AM; Parry DA; Zindy F; Roussel MF; Lees E; Moore KW; Mui AL
J Immunol; 2000 May; 164(9):4607-15. PubMed ID: 10779764
[TBL] [Abstract][Full Text] [Related]
40. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease.
Arendt T; Holzer M; Gärtner U
J Neural Transm (Vienna); 1998; 105(8-9):949-60. PubMed ID: 9869328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
